Nurix Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Nurix Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Nurix Therapeutics Inc
Rating: 1.13540275
Author: Trendlyne DVM scores

Momentum Trap

about

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated disc...

16.00 -0.18 (-1.11%)

28.89% Fall from 52W High

529.1K

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Nurix Therapeutics Inc is on 19 May 2026 for the purpose of Nurix Therapeutics Inc Annual General Meeting for 2026 See details

Low Financial Strength

11.1 / 100

Expensive Valuation

12.0 / 100

Technically Neutral

56.6 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 89%

17 analysts

Nurix Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Nurix Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated disc...

28.89% Fall from 52W High

SWOT Analysis

Nurix Therapeutics Inc Live Price Chart